Skip to main content

Table 3 The baseline characteristics of patients after PSM

From: The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study

CharacteristicsAll patients, no. (%), 608 (100)
Surgery, 165 (27.1)Non-surgery, 443 (72.9)P value
Gender  0.977
 Male135 (81.8)362 (81.7) 
 Female30 (18.2)81 (18.3) 
Age at diagnosis  0.765
 30–447 (4.2)12 (2.7) 
 45–5969 (41.8)179 (40.4) 
 60–7471 (43.1)201 (45.4) 
 75–8418 (10.9)51 (11.5) 
Ethnicity  0.511
 White116 (70.3)324 (73.1) 
 Black23 (13.9)65 (14.7) 
 Others26 (15.8)54 (12.2) 
Marital status  0.284
 Married100 (60.6)257 (58) 
 Single57 (34.5)174 (39.3) 
 Others8 (4.9)12 (2.7) 
AJCC T stage  0.635
 T155 (33.4)145 (32.7) 
 T251 (30.9)121 (27.3) 
 T356 (33.9)159 (35.9) 
 T42 (1.2)14 (3.2) 
 TX1 (0.6)4 (0.9) 
Year of diagnosis  0.228
 2004–200646 (27.9)107 (24.2) 
 2007–200949 (29.7)116 (26.2) 
 2010–201228 (17)109 (24.6) 
 2013–201542 (25.4)111 (25) 
Tumor size  0.532
 ≤ 3 cm37 (22.4)84 (19) 
 3–5 cm38 (23)117 (26.4) 
 > 5 cm90 (54.6)242 (54.6) 
Tumor number  0.208
 1141 (85.5)402 (90.7) 
 218 (10.9)34 (7.7) 
 35 (3)5 (1.1) 
 > 31 (0.6)2 (0.5) 
Radiotherapy  0.796
 Yes11 (6.7)27 (6.1) 
 No154 (93.3)416 (93.9) 
Chemotherapy  0.950
 Yes77 (46.7)208 (47) 
 No88 (53.3)235 (53) 
Liver resection68 
 Wedge or segmental resection27 
 Lobectomy24 
 Extended lobectomy14 
 Hepatectomy3 
Non-liver resection97 
 Local tumor destruction30 
 Cryoablation2 
 Percutaneous ethanol injection5 
 Radiofrequency ablation53 
 Others7